top of page

Prurigo Nodularis

Age: 18 years and older 

Location: Rancho Santa Margarita, CA

More Information: 

Allergic Reaction

Clinical Trial for Prurigo Nodularis

We are conducting clinical studies on new treatments for Prurigo Nodularis. If you or anyone you know has been diagnosed with Prurigo Nodularis, is over the age of 18 and is interested in participating in a clinical trial, please complete our short form at the bottom of the page to determine your eligibility. A member of our team of medical professionals will then contact you to ask a few questions. Please be aware that the consultation is free, and there are no obligations.

Study Details

Sponsor: Sanofi Recherche & Développement


Summary: This study is a prospective, multinational, observational investigation designed to elucidate the real-world effectiveness and treatment patterns of dupilumab therapy in adult patients diagnosed with prurigo nodularis (PN).The primary objective of this study is to comprehensively characterize the real-world usage of dupilumab for the management of PN.In addition to this, the study aims to achieve several secondary objectives, including a detailed assessment of the medical history, socio-demographic and disease characteristics of dupilumab-treated PN patients, as well as the evaluation of the long-term real-world effectiveness of dupilumab therapy for PN. (summary from

Trial Name: A Prospective Observational Study of Patients Receiving Dupilumab for Prurigo Nodularis

Keywords: Prurigo Nodularis, Dupilumab, Dupixent, 

bottom of page